Background articles & web pages that may be useful for this webinar include (listed from newest to oldest):
- Laurie McGinley & Katie Shepherd. FDA advisers back Pfizer-BioNTech coronavirus vaccine for children 5 to 11, saying benefits outweigh risks. Washington Post, Oct. 26, 2021. https://www.washingtonpost.com/health/2021/10/26/covid-vaccine-children-pfizer
- Sharon LaFraniere & Noah Weiland. An F.D.A. panel recommends the Pfizer-BioNTech vaccine for young children. New York Times, Oct. 26, 2021. https://www.nytimes.com/live/2021/10/25/world/covid-vaccine-boosters/pfizer-fda-covid-vaccine-kids
- Noah Weiland & Sharon LaFraniere. The F.D.A. authorizes Moderna and J.&J. boosters and allows a mix-and-match booster strategy. New York Times, Updated Oct. 25, 2021. https://www.nytimes.com/live/2021/10/20/world/covid-vaccine-boosters#fda-mix-match-covid-booster-shots
- Apoorva Mandavilli. The C.D.C. endorses Moderna and J.&J. boosters for millions of Americans. New York Times, Updated Oct. 25, 2021. https://www.nytimes.com/live/2021/10/21/world/covid-vaccine-boosters#cdc-mix-match-booster-shot
- Sharon LaFraniere & Noah Weiland. F.D.A. Says Pfizer Vaccine’s Benefits Outweigh Key Risks in Children 5 to 11. New York Times, Updated Oct. 24, 2021. https://www.nytimes.com/2021/10/22/us/politics/pfizer-vaccine-children-5-to-11.html
- Centers for Disease Control and Prevention. Who Is Eligible for a COVID-19 Vaccine Booster Shot? Updated Oct. 22, 2021. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/booster-shot.html
- Carolyn Y. Johnson & Laurie McGinley. FDA review appears to pave the way for Pfizer-BioNTech vaccine for children 5 to 11. Washington Post, Oct. 22, 2021. https://www.washingtonpost.com/health/2021/10/22/pfizer-children-vaccine-5-to-11
- Lena H. Sun & Katie Shepherd. CDC signs off on Moderna and Johnson & Johnson boosters and says people can get a shot different from their original one. Washington Post, Oct. 21, 2021. https://www.washingtonpost.com/politics/2021/10/21/cdc-moderna-jj-booster-recommendation/
- Sara Y. Tartof, Jeff M. Slezak, et al. Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study. Lancet, 30:1407-16, Oct. 16, 2021. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02183-8/fulltext
- Scott Hensley. Moderna and J&J say their data supports COVID vaccine boosters. National Public Radio, Oct. 12, 2021. https://www.npr.org/sections/coronavirus-live-updates/2021/10/12/1045149078/moderna-and-j-j-say-their-data-supports-covid-vaccine-boosters
- Mary Van Beusekom. Protection, immune response fall after Pfizer COVID vaccine, data show. Center for Infectious Disease Research & Policy (CIDRAP), Oct. 7, 2021. https://www.cidrap.umn.edu/news-perspective/2021/10/protection-immune-response-fall-after-pfizer-covid-vaccine-data-show
- Lianna Matt McLernon. COVID vaccine-related myocarditis rare, usually mild, studies say. Center for Infectious Disease Research & Policy (CIDRAP), Oct. 7, 2021. https://www.cidrap.umn.edu/news-perspective/2021/10/covid-vaccine-related-myocarditis-rare-usually-mild-studies-say
- Stephanie Soucheray. Pfizer asks FDA to authorize COVID-19 vaccine in kids. Center for Infectious Disease Research & Policy (CIDRAP), Oct. 7, 2021. https://www.cidrap.umn.edu/news-perspective/2021/10/pfizer-asks-fda-authorize-covid-19-vaccine-kids
- Yinon M. Bar-on, Yair Goldberg, et al. Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel, New England Journal of Medicine 385:1393-1400, Oct. 7, 2021. https://www.nejm.org/doi/full/10.1056/NEJMoa2114255
- Hiam Chemaitelly, Patrick Tang, et al. Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar. New England Journal of Medicine, Oct. 6, 2021. https://www.nejm.org/doi/full/10.1056/NEJMoa2114114
- Francis Collins. The Latest on COVID-19 Boosters, NIH Director's Blog, Sept. 28, 2021. https://directorsblog.nih.gov/2021/09/28/the-latest-on-covid-19-boosters/
- Centers for Disease Control and Prevention. CDC Statement on ACIP Booster Recommendations. Sept. 24, 2021. https://www.cdc.gov/media/releases/2021/p0924-booster-recommendations-.html
- Helen Branswell. Advisory committee recommends wide swath of Americans be offered Covid-19 vaccine boosters. STAT, Sept. 23, 2021. https://www.statnews.com/2021/09/23/covid19-vaccine-boosters-cdc-acip/
- U.S. Food & Drug Administration. FDA Authorizes Booster Dose of Pfizer-BioNTech COVID-19 Vaccine for Certain Populations. Sept. 22, 2021. https://www.fda.gov/news-events/press-announcements/fda-authorizes-booster-dose-pfizer-biontech-covid-19-vaccine-certain-populations
- Johnson & Johnson. Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and Long-Lasting Protection of Single-Shot COVID-19 Vaccine in the U.S. Sept. 21, 2021. https://www.jnj.com/johnson-johnson-announces-real-world-evidence-and-phase-3-data-confirming-strong-and-long-lasting-protection-of-single-shot-covid-19-vaccine-in-the-u-s
- Erin Digitale. When can you vaccinate your kids? What we know as FDA prepares to consider data from studies. Stanford Medicine, Sept. 21, 2021. https://med.stanford.edu/news/all-news/2021/09/covid-19-vaccine-children.html
- Isabella Kwai, Benjamin Mueller, David C. Kaelber. The W.H.O. urges wealthy countries to halt booster shots and send more doses to poorer nations. New York Times, Aug. 13, 2021. https://www.nytimes.com/2021/08/04/world/who-covid-vaccine-boosters.html
- Mendel E. Singer, Ira B. Taub, et al. Risk of Myocarditis from COVID-19 Infection in People Under Age 20: A Population-Based Analysis. medRxiv, Jul. 27, 2021. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328065/